Company / AR per Share
Syndax Pharmaceuticals Inc AR per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.44
FY2025
5-year range
$0.00 / $0.44
FY2023-FY2025
Trend
+394.8%
vs FY2024
Sector context
#69 of 113
Health Care
What the data says
At $0.44, Syndax Pharmaceuticals Inc's ar per share ranks #69 of 113 in the Health Care sector. Improved from $0.00 to $0.44 over the past 2 years.
Based on SEC 10-K filings.
0.44 in FY2025.
Improved from $0.00 to $0.44 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#69 of 113 in Health CareTop 61% of 113This company $0.44 Sector average $28.83
▼
-98.5% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 394.8% year-over-year.
- Ranks #69 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.44 | +394.8% |
| FY2024 | $0.09 | - |
| FY2023 | $0.00 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026